Entdecken
- Entdecken
  Lernen Sie mehr über Gen- und Zelltherapie
- Educational Resources Directory
  Educational Resources Directory
- INTENS
  INtestinal Tissue ENgineering Solution
- LEARN
  Listening to the experience of participants in neurosurgical trials
Lernen Sie mehr über Gen- und Zelltherapie
Research Pathways
- Research Pathways
  Bringing new therapies from the lab to patients
- Wege der Forschung
  Neue Therapien aus dem Labor für Patienten
- ATMP Engage
  Advanced Therapy Medicinal Products Patient and Public Involvement and Engagement Working Group
- Actors and Network database
  Actors and Networks database
Bringing new therapies from the lab to patients
Über Uns
Unsere Teams und Partner*innen
Kontakt

Erkrankung

Alzheimer-Krankheit
Augenerkrankungen
Blutkrankheit
Diabetes
Dramerkrankung
Epidermolysis bullosa
Erkrankungen des Stütz- und Bewegungsapparats
Haut
Herzerkrankung
Huntington-Krankheit
Immunkrankheiten
Infantile Zerebralparese
Krebs
Lebererkrankung
Lungenerkrankung
Motoneuron-Krankheit
Multiple Sklerose
Muskeldystrophie
Nabelschnurblut
Neurologische Erkrankungen
Nierenerkrankung
Parkinson-Krankheit
Rückenmarksverletzungen
Schlaganfall
Seltene Erkrankungen
Spinale Muskelatrophie
Reproduktion und Fertilität

Thema

Aktuelles zu Stammzellen
Blutstammzellen
CAR-T Therapien
Derzeitige und potenzielle Verwendungen
Embryonale Stammzellen
Ethik und Gesellschaft
Factsheets
Forschung
Geneditierung
Gentherapie
Grundlagen der Zellen und Gene
Haut Stammzellen
Industrie
iPS Zellen
Klinische Studien
Methoden und Hilfsmittel
Modellierung von Krankheiten
MSC
Nabelschnurblut
Organoide
Patientenbeteiligung
Reprogramierung
Richtlinien & Vorschriften
Stammzellen entdecken
Tissue-Engineering
Ungeprüfte Behandlungen
Zelltherapie

Sprache auswählen

English
Français
Deutsch
Italiano
Polski
Español
Português

ATMP Engage PPI Directory

The PPI Directory contains patient and public involvement (PPI) resources for developers of cell and gene therapies, including toolkits, guidelines, advice, templates and case studies.

Brotkrumennavigation

ATMP Engage
PPI Directory

PPI Directory

Title

PPI Themes

PPI Themes
- PPI Basics and Benefits
- Standards for PPI
- Roles and Responsibilities
- PPI Pools/Lists of Organisations
- Knowledge Building
- Strategies/Statements/Policies on PPI
- Budgeting/Compensation
- Project Planning
- How/Who to Recruit
- Using Technology
- Training
- Maintaining/Supporting PPI
- Communication/Plain Language/Glossaries
- Case Studies
- Evaluating/Recording PPI Impact
- Feedback to/from PPI

Research Field

Research Field
- General
- Biomedical Lab
- Pharmaceutical
- ATMP/Gene Therapy Development
- Other

Organisation Type

Organisation Type
- Funder
- Academia
- Healthcare
- Regulatory Body
- HTA
- Industry
- Third Sector/Charity
- Other Organisation

Development Stage

Development Stage
- Identifying/Prioritising Patient Need
- Research and Clinical Development
- Regulatory Approval
- Health Technology Assessment
- Service Delivery

Audience

Audience
- Researchers/Developers
- Public/Patients
- Charity Sector
- Industry
- Other groups

Country

Country
- UK
- Europe
- North America
- Other countries

Content Type

Content Type
- Resource
- Journal
- Repository
- Article

toolkit
partnership
NHS

Knowledge Building✕
Standards for PPI✕

Showing 5 of 83 results.

Page 7 of 17

Public Involvement Network Advisory Group Terms of Reference

Terms of reference for patient carer representatives that help inform Scottish Medicines Consortium (SMC) processes, published by Healthcare Improvement Scotland (HIS) and SMC

Visit this Resource

Research Field

ATMP/Gene Therapy Development

Organisation Type

Third Sector/Charity

Development Stage

Health Technology Assessment
Service Delivery

Audience

Researchers/Developers
Public/Patients
Charity Sector
Industry

Country

Content Type

Resource

2020

Improving patient access to gene and cell therapies for rare diseases in Europe.

Report for the Rare Impact project - improving access to ATMPs by European Organisation for Rare Diseases (EURORDIS)

View this Resource

Research Field

ATMP/Gene Therapy Development

Organisation Type

Third Sector/Charity

Development Stage

Service Delivery

Audience

Researchers/Developers
Public/Patients
Charity Sector
Industry

Country

Europe

Content Type

Resource

2016

PREFER patient preferences project

PREFER project by European Patient Forum (EPF)

View this Resource

Research Field

General

Organisation Type

Third Sector/Charity

Development Stage

Identifying/Prioritising Patient Need
Research and Clinical Development
Regulatory Approval
Health Technology Assessment
Service Delivery

Audience

Researchers/Developers
Industry

Country

Europe

Content Type

Resource

2020

Health Outcomes Observatory (H2O) project

Project by European Patient Forum (EPF)

View this Resource

Research Field

General
Biomedical Lab
Pharmaceutical

Organisation Type

Third Sector/Charity

Development Stage

Identifying/Prioritising Patient Need
Research and Clinical Development

Audience

Researchers/Developers
Public/Patients
Charity Sector
Industry

Country

Europe

Content Type

Resource

2014

Revised framework for interaction between the European Medicines Agency and patients and consumers and their organisations

Generic PPI framework by the European Medicines Agency

Visit this Resource

Research Field

Other

Organisation Type

Regulatory Body

Development Stage

Regulatory Approval

Audience

Researchers/Developers
Public/Patients

Country

Europe

Content Type

Resource

Pagination

First page
Previous page
…
Seite 5
Seite 6
Seite 7
Seite 8
Seite 9
…
Next page
Last page

Who are we?

The Advanced Therapy Medicinal Products Patient and Public Involvement and Engagement Working Group (ATMP Engage) brings together UK-based stakeholders with an interest in ATMPs to discuss and collaborate on PPIE activity.

Learn more about ATMP Engage

Zurück nach oben

Footer menu

Bedingungen und Bestimmungen
Datenschutz
Zugang
Kontaktieren Sie uns

EuroGCT auf Facebook EuroGCT auf Twitter

Dieses Projekt wurde aus Mitteln des Forschungs- und Innovationsprogramms Horizont 2020 der Europäischen Union unter der Finanzhilfevereinbarung Nr. 965241 finanziert.

© Copyright 2020-2025 EuroGCT and contributing authors